Immunisation against the mycobacterial heat shock protein (hsp-65) has been proposed to lead to production of autoantibodies against human lactoferrin. Such antibodies occur in ulcerative colitis and in primary sclerosing cholangitis. This study analysed the distribution of hsp-65 and lactoferrin in biopsy specimens from patients with inflammatory bowel disease and primary sclerosing cholangitis and studied whether immunisation against mycobacterial hsp-65 resulted in production of antilactoferrin antibodies and vice versa. Polyclonal rabbit antihuman lactoferrin and monoclonal mouse anti-hsp-65 (ML30) were used for immunohistochemistry on biopsy specimens from patients with inflammatory bowel disease and primary sclerosing cholangitis. Rats were immunised against human lactoferrin and mycobacterial hsp-65 respectively. Antibody measurements were done by enzyme immunosorbent assays. It was found that lactoferrin and hsp-60165 were not codistributed. 
Immunisation against the mycobacterial heat shock protein (hsp-65) has been proposed to lead to production of autoantibodies against human lactoferrin. Such antibodies occur in ulcerative colitis and in primary sclerosing cholangitis. This study analysed the distribution of hsp-65 and lactoferrin in biopsy specimens from patients with inflammatory bowel disease and primary sclerosing cholangitis and studied whether immunisation against mycobacterial hsp-65 resulted in production of antilactoferrin antibodies and vice versa. Polyclonal rabbit antihuman lactoferrin and monoclonal mouse anti-hsp-65 (ML30) were used for immunohistochemistry on biopsy specimens from patients with inflammatory bowel disease and primary sclerosing cholangitis. Rats were immunised against human lactoferrin and mycobacterial hsp-65 respectively. Antibody measurements were done by enzyme immunosorbent assays. It was found that lactoferrin and hsp-60165 were not codistributed. Lactoferrin was found on vascular endothelium and in nonparenchymal liver celis both in inflamed and uninflamed tissues, but only in the hepatocytes of inflamed liver. ML30 reactivity was not inhibited by antilactoferrin antibodies. Rat 4 Lactoferrin is secreted not only by the mammary glands, but also by the pancreas, the kidneys, the mucosae of the endometrium, the seminal vesicles and by lachrymal, bronchial, and salivary glands.5 6 A receptor on the brush border of enterocytes binds lactoferrin, which may be of importance for iron absorption in the new born.7 Lactoferrin is probably also an important nonspecific defence factor at mucosal surfaces, owing to its antibacterial properties. [8] [9] [10] Furthermore, lactoferrin has powerful antiinflammatory properties, for example, by preventing complement activation through inhibition of classic C3 convertase,'1 by preventing the formation of hydroxyl radicals,'2 13 and by preventing bacterial lipopolysaccharide from activating polymorphonuclear neutrophil leucocytes (PMNL).14 Apart from production and secretion by exocrine glands, lactoferrin resides in the specific granules of PMNL,15 and becomes exocytosed upon activation of the cells. '6 Normally, the plasma concentration of lactoferrin is very low, but it increases during inflammation owing to stimulation/degranulation of PMNL.17 18 Lactoferrin is released in iron free form, and by iron chelation and subsequent elimination by the reticuloendothelial system circulating lactoferrin may contribute to the hyposideraemia seen in acute and chronic inflammation.17 19 microscopy. Thus, the rabbit antihuman lactoferrin antibodies failed to react with human IgA-antiendomysial antibodies bound to tissue sections of monkey oesophagus. Likewise, cross reactivity between rabbit antilactoferrin antibodies and secretory component was unlikely as no indirect immunofluorescence reaction was detected with secretory component on unfixed cryostat sections of rat liver and stomach, and considering the phylogenetically conserved structure of secretory component. 38 To obtain polyclonal anti-hsp-65 antibodies, rats were given repeated subcutaneous or intracutaneous injections of Freund's complete adjuvant (Difco). The rats were anaesthetised and bled by heart puncture.
Affinity purified biotinylated rabbit antimouse immunoglobulins (Dakopatts, Glostrup, Denmark) and swine antirabbit immunoglobulins (Dakopatts) were used as secondary antibodies for immunohistochemistry. Rabbit antirat immunoglobulin antiserum conjugated with alkaline phosphatase (Dakopatts) was used for the ELISAs.
ELISA
Microtitre plates were coated with 10 ,ug antigen/ml and incubated with rat immune serum diluted serially with phosphate buffered saline pH 7-6 containing 0.05% TWEEN-20. Details of the procedures have been described elsewhere.24 29 Immunohistochemistry Deparaffinised and rehydrated sections were treated with 3% hydrogen peroxide to inhibit endogenous peroxidase activity, and incubated with normal rabbit serum or normal swine serum respectively before immunostaining to prevent non-specific background. Incubation with ML30 MoAb, diluted 1: 1000-1:2000, or rabbit antilactoferrin antiserum, diluted 1:1 000, was carried out for 60 minutes at room temperature. In an attempt to block the reactivity of ML30 MoAb by rabbit antilactoferrin and vice versa, the tissue sections were preincubated with the 'blocking' antibody for 60 minutes. The secondary biotinylated antibodies were diluted 1:2000 (swine) or 1:1000 (rabbit) and incubated with the tissue sections for 60 minutes. Avidin complexed with biotinylated peroxidase was used as the visualisation system with hydrogen peroxide as substrate and diaminobenzidine as chromogen.
Results

Immunisation
The serum of rabbits and rats immunised with lactoferrin had high values of antilactoferrin antibodies detectable at dilutions >1:10 000 judged by ELISA (not illustrated). Tested by ELISA, the rat antilactoferrin immune serum samples also had low values of antibodies binding hsp-65 at serum dilutions up to 1: 16. Serum from rats given heat killed mycobacteria subcutaneously contained high concentrations of anti-hsp-65 antibodies, but no detectable antibodies against human lactoferrin (not illustrated). The ML30 MoAb did not bind lactoferrin as tested by ELISA (not illustrated). Distribution oflactoferin and hsp-60/65
The (Fig 1 a, b) .
Furthermore, the vascular endothelium of small vessels were positively stained for lactoferrin in normal as well as in inflamed tissue (not illustrated). Also the staining patterns achieved with ML30 MoAb were essentially the same in normal and inflamed tissues with a few notable exceptions: the villus epithelium of the small intestine was only stained in the normal tissues (Fig lc) , but not in Crohn's disease (Fig Id) . Similarly, the surface epithelium of the large intestine was positively stained in normal tissue specimens, but not in ulcerative colitis (not illustrated).
Staining for lactoferrin was seen intracellularly in non-parenchymal liver cells, but not in the hepatocytes of normal liver (Fig 2a) . Positive the liver specimen from a patient with primary sclerosing cholangitis, faint lactoferrin staining was detected also in the hepatocytes, apart from the intense staining of non-parenchymal cells (Fig 2b) . Lactoferrin was always seen in infiltrating PMNL. Figure 2c and d show the identical staining patterns for hsp-60/65 in a normal liver biopsy specimen and in the liver of a patient with primary sclerosing cholangitis. Discussion Lactoferrin, an iron binding protein with antimicrobial, anti-inflammatory, and immunoregulatory properties, normally occurs in high concentrations in mucosal secretions and in milk (for reviews, see7 39 A physiological function of lactoferrin may be to facilitate iron absorption by receptor mediated binding of holo-lactoferrin by enterocytes followed by transcytosis and iron release.7 51 Therefore, the finding of lactoferrin in enterocytes in this study could speculatively reflect endocytosed external protein.
We conclude that lactoferrin is distributed similarly in biopsy specimens of liver and intestine from normal and inflamed tissue. In both instances the non-parenchymal liver cells were positively stained, whereas signs of intracellular lactoferrin in the hepatocytes were seen only in liver sections from patient with primary sclerosing cholangitis. This supports the view that both non-parenchymal liver cells and hepatocytes participate in the clearance of circulating lactoferrin. A monoclonal antibody specific for mycobacterial hsp-65fhuman 
